Dr James Holland, MD | |
12100 Highway 49, Gulfport, MS 39503-3063 | |
(228) 867-5185 | |
(228) 867-5189 |
Full Name | Dr James Holland |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 38 Years |
Location | 12100 Highway 49, Gulfport, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063527356 | NPI | - | NPPES |
370009291 | Other | MS | RAILROAD MEDICARE |
00118024 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 15332 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hospital At Gulfport | 2466524012 | 376 |
News Archive
As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
Tohoku University researchers have found that trans-fatty acids promote cell death in a more direct manner than previously thought, leading to the development of atherosclerosis, a major cause of heart attacks and strokes.
› Verified 4 days ago
Entity Name | Memorial Hospital At Gulfport |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
Tohoku University researchers have found that trans-fatty acids promote cell death in a more direct manner than previously thought, leading to the development of atherosclerosis, a major cause of heart attacks and strokes.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James Holland, MD Po Box 1810, Gulfport, MS 39502-1810 Ph: (228) 867-5185 | Dr James Holland, MD 12100 Highway 49, Gulfport, MS 39503-3063 Ph: (228) 867-5185 |
News Archive
As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
Tohoku University researchers have found that trans-fatty acids promote cell death in a more direct manner than previously thought, leading to the development of atherosclerosis, a major cause of heart attacks and strokes.
› Verified 4 days ago